No serious side effects or abnormal laboratory findings were observed for either mosapride or teprenone. Therefore, we believe that the 5-HT 4 agonist, mosapride, can be a first-line drug to treat FD.

The present study was conducted to compare the clinical effectiveness of mosapride and teprenone in patients with FD. Methods: Prospective clinical comparative study with random allocation of open ...

Get detailed information on Mosapride, including pronunciation, uses, dosage guidelines, indications, and instructions on how and when to take it and when to avoid it. The updated prescription ...